|Table of Contents|

Research progress on non-coding RNA in the occurrence and development of gynecological tumors based on Warburg effect

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 15
Page:
2882-2891
Research Field:
Publishing date:

Info

Title:
Research progress on non-coding RNA in the occurrence and development of gynecological tumors based on Warburg effect
Author(s):
XIE Yingying12LI Dongdong1ZHANG Xiaoqing3MA Chunzheng1HU Yiyang12ZHAO Ningning12ZHANG Juan12
1.The Second Affiliated Hospital of Henan University of Chinese Medicine,Henan Zhengzhou 450002,China;2.The Second Clinical Medical College,Henan University of Chinese Medicine,Henan Zhengzhou 450046,China;3.The First Affiliated Hospital of Zhengzhou University,Henan Zhengzhou 450052,China.
Keywords:
Warburg effectnon-coding RNAsgynecological tumors
PACS:
R737.3
DOI:
10.3969/j.issn.1672-4992.2024.15.029
Abstract:
The Warburg effect is a prominent feature of tumor cell metabolism.In recent years,many molecules related to the Warburg effect have been discovered.Among them,various non-coding RNAs(including lncRNAs,miRNAs and circRNAs) have been shown to play an important role in the development of gynecological tumors by regulating the Warburg effect.Based on the Warburg effect,this paper reviews the mechanism and research progress of non-coding RNA in the occurrence and development of gynecological tumors,and summarizes the direct and indirect regulation mechanism of non-coding RNA on the Warburg effect in gynecological tumors,aiming to provide reference for early diagnosis,targeted therapy and prognosis evaluation of gynecological malignant tumors,and provide new ideas for clinical diagnosis,treatment and basic research of gynecological tumors.

References:

[1] BERGHUIS AY,PIJNENBORG JFA,BOLTJE TJ,et al.Sialic acids in gynecological cancer development and progression:Impact on diagnosis and treatment[J].Int J Cancer,2022,150(4):678-687.
[2] COCOMAZZI G,DEL PUP L,CONTU V,et al.Gynecological cancers and microbiota dynamics:Insights into pathogenesis and therapy[J].Int J Mol Sci,2024,25(4):2237.
[3] CHEN Q,SHEN S,LYU N,et al.Role of microRNAs in glycolysis in gynecological tumors(Review)[J].Int J Oncol,2023,62(5):63.
[4] OGAWA C,HIRASAWA A,IDA N,et al.Hereditary gynecologic tumors and precision cancer medicine[J].J Obstet Gynaecol Res,2022,48(5):1076-1090.
[5] VALLONE C,RIGON G,GULIA C,et al.Non-coding RNAs and endometrial cancer[J].Genes(Basel),2018,9(4):187.
[6] ZHAN L,LI J,WEI B,et al.Long non-coding RNAs in ovarian cancer[J].Exp Clin Cancer Res,2018,37(1):120.
[7] 鲁艳明,黄翠艳,王月,等.长链非编码RNA在妇科恶性肿瘤中研究进展[J].中华肿瘤防治杂志,2017,24(24):1751-1756. LU YM,HUANG CY,WANG Y,et al.Research of long non-coding RNA in gynecologic malignancies[J].Chinese Journal of Cancer Prevention and Treatment,2017,24(24):1751-1756
[8] ZHAO D,REN C,YAO Y,et al.Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network[J].Cell Biochem,2020,121(3):2437-2446.
[9] TRAN Q,LEE H,PARK J,et al.Targeting cancer metabolism-revisiting the Warburg effects[J].Toxicol Res,2016,32(3):177-193.
10] 彭瑞,赵丽,赵琦,等.肿瘤糖代谢机制的研究进展[J].国际检验医学杂志,2021,42(07):872-876. PENG R,ZHAO L,ZHAO Q,et al.Advances in tumor glucose metabolism[J].International Journal of Laboratory Medicine,2021,42(07):872-876.
11] ZHANG C,LIU N.Noncoding RNAs in the glycolysis of ovarian cancer[J].Front Pharmacol,2022,13:855488.
12] FUKUSHI A,KIM HD,CHANG YC,et al.Revisited metabolic control and reprogramming cancers by means of the Warburg effect in tumor cells[J].Int J Mol Sci,2022,23(17):10037.
13] 牛亚倩,常钰玲,刘芳,等.microRNA在肝细胞癌有氧糖酵解中的调控作用[J].临床肝胆病杂志,2019,35(09):2082-2084. NIU YQ,CHANG YL,LIU F,et al.Regulatory role of microRNA in aerobic glycolysis in hepatocellular carcinoma[J].J Clin Hepatol,2019,35(09):2082-2084.
14] 段艺菲,赵清喜,荆雪.长链非编码RNA对原发性肝癌中糖酵解途径的影响机制[J].临床肝胆病杂志,2019,35(06):1374-1376. DUAN YF,ZHAO QX,JING X.Effect of long non-coding RNAs on glycolytic pathway in primary liver cancer and related mechanisms[J].J Clin Hepatol,2019,35(06):1374-1376.
[15] 张军,欧阳满照.非编码RNA在结肠癌糖代谢重编程中的作用[J].海南医学,2022,33(10):1317-1323. ZHANG J,OUYANG MZ.Role of non-coding RNA in glucose reprogramming in colon cancer[J].Hainan Med J,2022,33(10):1317-1323.
[16] 黄锦源,代荫梅.长链非编码RNA UCA1与妇科恶性肿瘤关系的研究进展[J].医学综述,2022,28(12):2379-2384. HUANG JY,DAI YM.Research progress in relationship between long non-coding RNA UCA1 and malignant gynecologic tumors[J].Medical Recapitulate,2022,28(12):2379-2384.
[17] XIAO Y,BI M,GUO H,et al.Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis[J].EBioMedicine,2022,79:104001.
[18] ZHANG R,SIU MKY,NGAN HYS,et al.Molecular biomarkers for the early detection of ovarian cancer[J].Int J Mol Sci,2022,23(19):12041.
[19] DAVOODVANDI A,RAFIYAN M,MANSOURNIA MA,et al.MicroRNA and gynecological cancers:Focus on miR-195[J].Pathol Res Pract,2023,249:154784.
[20] HAN RL,WANG FP,ZHANG PA,et al.miR-383 inhibits ovarian cancer cell proliferation,invasion and aerobic glycolysis by targeting LDHA[J].Neoplasma,2017,64(2):244-252.
[21] GU ZW,HE YF,WANG WJ,et al.MiR-1180 from bone marrow-derived mesenchymal stem cells induces glycolysis and chemoresistance in ovarian cancer cells by upregulating the Wnt signaling pathway[J].J Zhejiang Univ Sci B,2019,20(3):219-237.
[22] 武红,李枫,张曦辉,等.miR-370-3p靶向HDAC4调节卵巢癌SKOV3细胞的生长和代谢研究[J].中国肿瘤临床,2020,47(23):1194-1199. WU H,LI F,ZHANG XH,et al.MicroRNA-370-3p targets histone deacetylase 4 to regulate growth and metabolism of ovarian cancer SKOV3 cells[J].Chin J Clin Oncol,2020,47(23):1194-1199.
[23] LU J,ZHEN S,TUO X,et al.Downregulation of DNMT3A attenuates the Warburg effect,proliferation,and invasion via promoting the inhibition of miR-603 on HK2 in ovarian cancer[J].Technol Cancer Res Treat,2022,21:15330338221110668.
[24] LU J,CHEN H,HE F,et al.Ginsenoside 20(S)-Rg3 upregulates HIF-1α-targeting miR-519a-5p to inhibit the Warburg effect in ovarian cancer cells[J].Clin Exp Pharmacol Physiol,2020,47(8):1455-1463.
[25] ZHANG S,PEI M,LI Z,et al.Double-negative feedback interaction between DNA methyltransferase 3A and microRNA-145 in the Warburg effect of ovarian cancer cells[J].Cancer Sci,2018,109(9):2734-2745.
[26] TUO X,ZHOU Y,YANG X,et al.miR-532-3p suppresses proliferation and invasion of ovarian cancer cells via GPNMB/HIF-1α/HK2 axis[J].Pathol Res Pract,2022,237:154032.
[27] LIU D,LI H.Long non-coding RNA GEHT1 promoted the proliferation of ovarian cancer cells via modulating the protein stability of HIF1α[J].Biosci Rep,2019,39(5):BSR20181650.
[28] LIU Y,FU X,WANG X,et al.Long non coding RNA OIP5 AS1 facilitates the progression of ovarian cancer via the miR 128 3p/CCNG1 axis[J].Mol Med Rep,2021,23(5):388.
[29] LIU Y,HE X,CHEN Y,et al.Long non-coding RNA LINC00504 regulates the Warburg effect in ovarian cancer through inhibition of miR-1244[J].Mol Cell Biochem,2020,464(1-2):39-50.
[30] GUAN N,ZHENG H,WU X,et al.SP1-regulated non-coding RNA SNHG22 promotes ovarian cancer growth and glycolysis[J].Cancer Manag Res,2021,13:7299-7309.
[31] XU H,SUN X,HUANG Y,et al.Long non coding RNA NEAT1 modifies cell proliferation,colony formation,apoptosis,migration and invasion via the miR 4500/BZW1 axis in ovarian cancer[J].Mol Med Rep,2020,22(4):3347-3357.
[32] LI X,ZHANG Y,WANG X,et al.Long non-coding RNA CTSLP8 mediates ovarian cancer progression and chemotherapy resistance by modulating cellular glycolysis and regulating c-Myc expression through PKM2[J].Cell Biol Toxicol,2022,38(6):1027-1045.
[33] XU S,JIA G,ZHANG H,et al.LncRNA HOXB-AS3 promotes growth,invasion and migration of epithelial ovarian cancer by altering glycolysis[J].Life Sci,2021,264:118636.
[34] TAO LM,GONG YF,YANG HM,et al.LINC00662 promotes glycolysis and cell survival by regulating miR- 375/HIF-1α axis in ovarian cancer[J].J Biol Regul Homeost Agents,2020,34(3):467-477.
[35] HOU W,ZHANG Y.Circ_0025033 promotes the progression of ovarian cancer by activating the expression of LSM4 via targeting miR-184[J].Pathol Res Pract,2021,217:153275.
[36] LIN C,XU X,YANG Q,et al.Circular RNA ITCH suppresses proliferation,invasion,and glycolysis of ovarian cancer cells by up-regulating CDH1 via sponging miR-106a[J].Cancer Cell Int,2020,20:336.
[37] XIE W,LIU LU,HE C,et al.Circ_0002711 knockdown suppresses cell growth and aerobic glycolysis by modulating miR-1244/ROCK1 axis in ovarian cancer[J].J Biosci,2021,46:21.
[38] 程淑清,李海波,闫露露.环状RNA_0001649抑制卵巢癌SKOV3细胞糖酵解、增殖、迁移和侵袭研究[J].中国卫生检验杂志,2022,32(23):2879-2882. CHENG SQ,LI HB,YAN LL.Circular RNA_0001649 inhibits glycolysis,proliferation,migration and invasion of ovarian cancer SKOV3 cells[J].Chin J Health Lab Tec,2022,32(23):2879-2882.
[39] SONG R,CHAI T,LIU J,et al.Knockdown of circMFN2 inhibits cell progression and glycolysis by miR-198/CUL4B pathway in ovarian cancer[J].J Biochem Mol Toxicol,2023,37(8):e23383.
[40] VOLKOVA LV,PASHOV AI,OMELCHUK NN.Cervical carcinoma:Oncobiology and biomarkers[J].Int J Mol Sci,2021,22(22):12571.
[41] GUO M,ZHAO X,YUAN X,et al.MiR-let-7a inhibits cell proliferation,migration,and invasion by down-regulating PKM2 in cervical cancer[J].Oncotarget,2017,8(17):28226-28236.
[42] 许娟秀,吴海根.沉默HBXIP通过抑制miR-135a调控宫颈癌CaSki细胞的SCAI表达、上皮-间充质转化和糖酵解[J].中国病理生理杂志,2019,35(08):1423-1431. XU JX,WU HG.Knock-down of HBXIP regulates SCAI expression,epithelial-mes enchymal transition,and glucose metabolism in cervical cancer CaSki cells via inhibiting miR-135a[J].Chinese Journal of Pathophysiology,2019,35(08):1423-1431.
[43] 张瑜,张利利,平毅,等.微RNA-125b靶向调控M2型丙酮酸激酶影响宫颈癌SiHa细胞机制验证[J].中国药物与临床,2020,20(10):1597-1600. ZHANG Y,ZHANG LL,PING Y,et al.Validating the mechanism underlying the effect of miR-125b targeted regulation of PKM2 on cervical cancer SiHa cells[J].Chinese Remedies & Clinics,2020,20(10):1597-1600.
[44] SHAO X,ZHENG X,MA D,et al.Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis[J].Biosci Rep,2021,41(7):BSR20200533.
[45] LI L,MA Y,MAERKEYA K,et al.LncRNA OIP5-AS1 rgulates the Warburg effect through miR-124-5p/IDH2/HIF-1α pathway in cervical cancer[J].Front Cell Dev Biol,2021,9:655018.
[46] ZHAO Z,JI M,WANG Q,et al.miR-16-5p/PDK4-mediated metabolic reprogramming is involved in chemoresistance of cervical cancer[J].Mol Ther Oncolytics,2020,17:509-517.
[47] LI P,ZHANG Q,TANG H.INPP1 up-regulation by miR-27a contributes to the growth,migration and invasion of human cervical cancer[J].J Cell Mol Med,2019,23(11):7709-7716.
[48] 黄红丽,杨一,王桂芳,等.CYTOR通过调控miR-125b-5p/HK2通路促进宫颈癌细胞有氧糖酵解、增殖和侵袭[J].中南医学科学杂志,2019,47(04):367-373. HUANG HL,YANG Y,WANG GF,et al.CYTOR promotes aerobic glycolysis,proliferation and invasion of cervical cancer cells by regulating miR-125b-5p/HK2 pathway[J].Journal of Medical Sciencein Central Sauh China,2019,47(04):367-373.
[49] 云燕,吴江,高志勇.依托咪酯通过调控lncRNA SLCO4A1-AS1表达影响宫颈癌HeLa细胞增殖、迁移、侵袭及糖酵解的机制研究[J].现代医学,2022,50(10):1314-1321. YUN Y,WU J,GAO ZY.The mechanism of etomidate affecting the proliferation,migration,invasion,and glycolysis of cervical cancer HeLa cells by regulating the expression of lncRNA SLCO4A1 AS1[J].Mod Med J,2022,50(10):1314-1321.
[50] HU XL,HUANG XT,ZHANG JN,et al.Long noncoding RNA MIR210HG is induced by hypoxia-inducible factor 1α and promotes cervical cancer progression[J].Am J Cancer Res,2022,12(6):2783-2797.
[51] LI X,ZHANG C,TIAN Y.Long non-coding RNA TDRG1 promotes hypoxia-induced glycolysis by targeting the miR-214-5p/SEMA4C axis in cervical cancer cells[J].J Mol Histol,2021,52(2):245-256.
[52] 邵学成,刘国艳.长链非编码RNA,微小RNA和环状RNA在宫颈癌中的作用[J].河北医科大学学报,2021,42(08):980-985. SHAO XC,LIU GY.The role of long chain non coding RNAs, microRNAs, and cyclic RNAs in cervical cancer[J].Journal of HeBei Medical University,2021,42(08):980-985.
[53] ZHOU Y,SHEN L,WANG YZ,et al.The potential of ciRS-7 for predicting onset and prognosis of cervical cancer[J].Neoplasma,2020,67(2):312-322.
[54] ZHANG Y,ZHAO L,YANG S,et al.CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression[J].J Exp Clin Cancer Res,2020,39(1):281.
[55] LI Y,TANG Y,LI Z,et al.CircSOS2 promotes cervical squamous cell carcinoma by regulation of proliferation,cell cycle,apoptosis,migration,invasion,and glycolysis by targeting miR-543/FNDC3B axis[J].Arch Biochem Biophys,2021,708:108925.
[56] BANI MA,MAULARD A,MORICE P,et al.Integration of the molecular classification of endometrial carcinoma to select patients for fertility sparing strategies[J].Anticancer Res,2024,44(2):445-452.
[57] MAKKER V,MACKAY H,RAY-COQUARD I,et al.Endometrial cancer[J].Nat Rev Dis Primers,2021,7(1):88.
[58] KAUR JAWANDA I,SONI T,KUMARI S,et al.Deciphering the potential of proteomic-based biomarkers in women's reproductive diseases:empowering precision medicine in gynecology[J].Biomarkers,2024,29(1):7-17.
[59] 陈静青,万淑琼,王楚平,等.miRNA-3613在子宫内膜癌组织中的表达及对子宫内膜癌细胞增殖和有氧糖酵解的影响[J].中国性科学,2023,32(03):88-93. CHEN JQ,WAN SQ,WANG CP,et al.Expression of miRNA-3613 in endometrial cancer tissue and its effect on proliferation and aerobic glycolysis of endometrial cancer cells[J].Chinese Journal of Human Sexuality,2023,32(03):88-93.
[60] DONG P,XIONG Y,KONNO Y,et al.Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway[J].J Exp Clin Cancer Res,2021,40(1):216.
[61] JIANG Y,CHEN J,LING J,et al.Construction of a Glycolysis-related long noncoding RNA signature for predicting survival in endometrial cancer[J].J Cancer,2021,12(5):1431-1444.
[62] XING TR,CHEN P,WU JM,et al.UPF1 participates in the progression of endometrial cancer by inhibiting the expression of lncRNA PVT1[J].Onco Targets Ther,2020,13:2103-2114.
[63] ZHANG G,MA A,JIN Y,et al.LncRNA SNHG16 induced by TFAP2A modulates glycolysis and proliferation of endometrial carcinoma through miR-490-3p/HK2 axis[J].Am J Transl Res,2019,11(11):7137-7145.
[64] WANG B,LU Y,FENG E.hsa_circ_0001610 knockdown modulates miR-646-STAT3 axis to suppress endometrial carcinoma progression[J].J Gene Med,2021,23(6):e3337.

Memo

Memo:
National Natural Science Foundation of China(No.82204981);国家自然科学基金资助项目(编号:82204981);河南省特色骨干学科中医学学科建设项目(编号:STG-ZYX06-202145);河南省中医药科学研究专项课题(编号:2021JDZX2002;20-21ZY2115);河南省中医院博士科研基金(编号:2022BSJJ08,2023BSJJ02);河南中医药大学研究生科研创新项目(编号:2022KYCX057)
Last Update: 2024-06-28